Women Experience Faster Cognitive Decline with Age

A new analysis finds higher baseline cognition scores for aging women, but a more rapid drop once cognitive decline begins.

2:18 PM

Author | Haley Otman

drawing of brain in blue ink with lab note badge in yellow bottom right
Michigan Medicine

Women may start middle age with stronger brain function than men, but as they get older, women's cognition declines faster.

That's according to a new analysis from more than 26,000 Black and white men and women who had participated in one of five long-term cohort studies. The researchers found that women had significantly faster declines in overall cognition and executive function, the brain processes used in problem-solving, planning and managing your time. However, memory decline was comparable between men and women.

"We estimate that cognitive function in women declined around five years faster than their ages would suggest," says lead author Deborah Levine, M.D., M.P.H., an associate professor of internal medicine and neurology at Michigan Medicine, and director of its Cognitive Health Services Research Program. "Differences in biological, genetic, social and lifestyle factors between men and women might contribute to faster cognitive decline in women, and more research is needed."

Researchers attribute the higher initial cognitive levels in women to greater cognitive reserve. Women's higher initial scores might delay detecting thinking difficulties, so it's important for loved ones and physicians to closely monitor older women for the first signs of cognitive decline, Levine says.

Paper cited: "Sex Differences in Cognitive Decline Among US Adults," JAMA Network Open. DOI: 10.1001/jamanetworkopen.2021.0169


More Articles About:

Lab Notes Gender Alzheimer's Disease Womens Health All Research Topics Health Care Delivery, Policy and Economics Geriatrics Demographics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.